These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19118147)

  • 1. Targeting cyst initiation in ADPKD.
    Leuenroth SJ; Crews CM
    J Am Soc Nephrol; 2009 Jan; 20(1):1-3. PubMed ID: 19118147
    [No Abstract]   [Full Text] [Related]  

  • 2. Does TNF-alpha enhance cystogenesis in ADPKD?
    Pirson Y
    Nephrol Dial Transplant; 2008 Dec; 23(12):3773-5. PubMed ID: 18820281
    [No Abstract]   [Full Text] [Related]  

  • 3. Autosomal dominant polycystic kidney disease: pathophysiology and treatment.
    Rapoport J
    QJM; 2007 Jan; 100(1):1-9. PubMed ID: 17164322
    [No Abstract]   [Full Text] [Related]  

  • 4. TRPP channels and polycystins.
    Hofherr A; Köttgen M
    Adv Exp Med Biol; 2011; 704():287-313. PubMed ID: 21290302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant polycystic kidney disease and mTOR inhibitors: the narrow road between hope and disappointment.
    Ponticelli C; Locatelli F
    Nephrol Dial Transplant; 2010 Dec; 25(12):3809-12. PubMed ID: 20798121
    [No Abstract]   [Full Text] [Related]  

  • 6. Polycystic kidney disease: pathogenesis and potential therapies.
    Takiar V; Caplan MJ
    Biochim Biophys Acta; 2011 Oct; 1812(10):1337-43. PubMed ID: 21146605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease].
    Joly D
    Med Sci (Paris); 2011 Mar; 27(3):249-51. PubMed ID: 21447293
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel dephosphorylation-activated conductance in a mouse renal collecting duct cell line.
    Laycock S; Taylor HC; Haigh C; Lee AT; Cooper GJ; Ong AC; Robson L
    Exp Physiol; 2009 Aug; 94(8):914-27. PubMed ID: 19429644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.
    Happé H; Leonhard WN; van der Wal A; van de Water B; Lantinga-van Leeuwen IS; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2009 Jul; 18(14):2532-42. PubMed ID: 19401297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adult dominant polycystic kidney disease: molecular mechanisms and new therapeutic possibilities].
    Rodríguez Pérez JC; Torres MJ
    Nefrologia; 2006; 26(6):651-2. PubMed ID: 17227240
    [No Abstract]   [Full Text] [Related]  

  • 11. ARPKD and ADPKD: first cousins or more distant relatives?
    Kaimori JY; Germino GG
    J Am Soc Nephrol; 2008 Mar; 19(3):416-8. PubMed ID: 18272839
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polycystic kidney disease].
    Higashihara E
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():83-90. PubMed ID: 17899832
    [No Abstract]   [Full Text] [Related]  

  • 13. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.
    Bonnet CS; Aldred M; von Ruhland C; Harris R; Sandford R; Cheadle JP
    Hum Mol Genet; 2009 Jun; 18(12):2166-76. PubMed ID: 19321600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel?
    Walz G
    Nephrol Dial Transplant; 2006 Jul; 21(7):1752-7. PubMed ID: 16705023
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel human pathological mutations. Gene symbol: PKD1. Disease: human autosomal dominant polycystic kidney disease.
    Li L
    Hum Genet; 2007 Nov; 122(3-4):413-4. PubMed ID: 18350644
    [No Abstract]   [Full Text] [Related]  

  • 16. [New therapies for ADPKD].
    Rathaus M
    G Ital Nefrol; 2007; 24(6):526-34. PubMed ID: 18278756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does dopamine connect the dots in ADPKD?
    Chapman AB
    Kidney Int; 2015 Feb; 87(2):279-80. PubMed ID: 25635722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant polycystic kidney disease: a case study.
    Phillips A
    Nephrol Nurs J; 2009; 36(1):41-7. PubMed ID: 19271623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kidney volume and renal function in ADPKD].
    Horie S; Muto S
    Nihon Jinzo Gakkai Shi; 2012; 54(4):501-5. PubMed ID: 24236340
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy for polycystic kidney disease? It's water, stupid!
    Grantham JJ
    J Am Soc Nephrol; 2008 Jan; 19(1):1-7. PubMed ID: 18032792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.